After Lupin Launch, Cipla Introduces US Brovana Rival
Company Launches Generic Version Of Sunovion’s Arformoterol Brand
After Lupin’s launch of an authorized generic, Cipla has entered the US market with its own generic rival to Sunovion’s Brovana, after receiving the FDA approval for the inhalation solution. Axar Pharma and Glenmark also currently hold approvals and Teva a tentative approval for arformoterol tartrate abbreviated new drug applications.
